Colorado was the first state to cap a drug’s price – then a federal court stepped in

By Shweta Kumar, Assistant Professor of Law, University of Kentucky

Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set upper limits on what state agencies, insurers and other purchasers may pay or be reimbursed for certain high-cost drugs dispensed to patients in the state.

In fall 2025, the Colorado board capped Enbrel, an immunosuppressant drug made by Amgen used to treat rheumatoid arthritis, psoriasis and other autoimmune…

Read complete article

~	Now that the World Cup is over, can host cities turn their investment into a lasting social impact?

~	The rise of Yemeni coffeehouses in Dearborn and beyond

~	What Allegheny County’s new court-ordered mental health treatment program can and can’t do

~	Amid grinding war, protesting Ukrainians still want their voices and values heard at home

~	Eight lifesaving ways to improve wildfire risk management

~	The next skincare revolution could start with your immune system

~	Why handheld fans are not cool for the planet

~	The government wants to tap $4 trillion in super to address Australia’s challenges. It’s a risky strategy

~	Tracing art from impressionism through to abstract expressionism, and from Ohio to Adelaide

~	Kids do feel the cold. So why won’t they wear a jumper?